Cargando…
Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020
This cohort study used Medicaid data to examine trends in the use of and spending for hemophilia pharmaceuticals from 2005 to 2020.
Autores principales: | Hernandez, Inmaculada, Rowe, Deanna, Gellad, Walid F, Good, Chester B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173373/ https://www.ncbi.nlm.nih.gov/pubmed/34076701 http://dx.doi.org/10.1001/jamanetworkopen.2021.12044 |
Ejemplares similares
-
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2019) -
Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees
por: Cochran, Gerald, et al.
Publicado: (2018) -
Trends in Comorbid Conditions Among Medicaid Enrollees With HIV
por: Cole, Megan B, et al.
Publicado: (2019) -
A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021) -
Longitudinal trends in enrollees’ employment and student status after Medicaid expansion
por: Tipirneni, Renuka, et al.
Publicado: (2022)